Research shows that a protein called STING moves into the power plants of heart cells in diabetes, breaking their normal energy system and forcing them to produce harmful lactate instead. A 2026 study in Circulation Research found that removing STING or boosting a protective molecule called hydrogen sulfide reversed this damage and restored heart function in diabetic mice, suggesting new treatment targets for diabetic heart disease.
According to Gram Research analysis, scientists discovered that a protein called STING plays a surprising role in how diabetes harms the heart. When blood sugar is high, STING moves into the power plants of heart cells (mitochondria) and forces them to switch to an inefficient energy system, producing harmful lactate buildup. The study used diabetic mice and lab-grown heart cells to show that blocking STING or boosting a protective molecule called hydrogen sulfide could reverse this damage and restore normal heart function. This finding opens a new path for treating diabetic heart disease, one of the most serious complications of diabetes.
Key Statistics
A 2026 research article published in Circulation Research found that STING protein relocates to mitochondria in diabetic heart cells, disrupting normal energy production and causing lactate accumulation in cardiac tissue.
In diabetic mice, genetic removal of STING or treatment with a hydrogen sulfide-boosting drug (GYY4137) significantly improved heart pumping ability and reduced lactate overproduction, according to the 2026 Circulation Research study.
The 2026 study identified that diabetes-associated depletion of hydrogen sulfide allows STING to undergo chemical modifications that send it into mitochondria, where it activates the glycolytic enzyme ENO1 and disrupts normal heart cell energy production.
The Quick Take
- What they studied: How a protein called STING damages heart cells in people with diabetes by forcing them to use an inefficient energy system
- Who participated: Diabetic mice (both genetically diabetic and those made diabetic through diet and chemicals) and heart cells grown in the laboratory
- Key finding: STING moves into the mitochondria (power plants of cells) in diabetic hearts, breaks the normal energy system, and forces cells to produce too much lactate, a harmful byproduct. Removing STING or adding a protective molecule called hydrogen sulfide reversed this damage.
- What it means for you: This research suggests new treatments for diabetic heart disease may be possible by targeting STING or boosting hydrogen sulfide. However, these findings are from animal studies and lab work, so human testing is still needed before any new treatments become available.
The Research Details
Researchers used two types of diabetic mice—one genetically programmed to be diabetic and another made diabetic through a high-fat diet plus a chemical injection. They examined heart tissue using advanced imaging, looked at individual cells with genetic sequencing, and studied isolated heart cells in the laboratory. To understand the mechanism, they removed the STING gene from some mice and treated others with a drug that boosts hydrogen sulfide levels. They measured how well the heart pumped, how the mitochondria functioned, and how much lactate accumulated in the tissue.
The team used specialized equipment to track energy production in real-time, measured chemical changes in heart tissue using labeled glucose, and examined the physical structure of mitochondria under electron microscopes. They also studied how STING protein was chemically modified and how it interacted with other proteins inside the mitochondria.
This multi-layered approach allowed researchers to see both the big picture (how the whole heart was affected) and the molecular details (exactly how STING was causing damage at the protein level).
Understanding the exact mechanism of how diabetes damages the heart is crucial because it reveals new targets for treatment. Rather than just treating symptoms, researchers can now potentially prevent the root cause of the damage. This study shows that STING isn’t just an immune protein—it also controls how cells produce energy, which is important for developing better therapies.
This research was published in Circulation Research, a highly respected journal for heart disease studies. The study used multiple animal models and confirmed findings in laboratory-grown cells, which strengthens confidence in the results. The researchers measured many different aspects of the problem (genetics, proteins, energy production, and heart function) rather than just one marker. However, all experiments were conducted in mice and cells, not humans, so results may not directly translate to people with diabetes.
What the Results Show
When researchers exposed heart cells to high levels of fat (mimicking diabetes), a protein called STING moved from the cell’s outer area into the mitochondria—the power plants that produce energy. Once inside the mitochondria, STING stuck to another protein called TOM40 and disrupted the normal process of bringing proteins into the mitochondria. This disruption broke the mitochondria’s ability to produce energy efficiently.
As a result, the heart cells switched to an emergency energy system called glycolysis, which produces lactate as a waste product. The diabetic hearts accumulated dangerous levels of lactate, which further damaged the cells. When researchers removed the STING gene from diabetic mice, the mitochondria worked better, lactate levels dropped, and the heart’s pumping ability improved significantly.
The researchers also discovered why this happens in diabetes: the body produces less of a protective molecule called hydrogen sulfide when blood sugar is high. This loss of protection allows STING to be chemically modified in a way that sends it into the mitochondria. When they gave diabetic mice a drug that restored hydrogen sulfide levels, it prevented STING from entering the mitochondria and protected the heart from damage.
The study showed that STING’s harmful effects were specific to the mitochondria—the protein had to physically move into the power plants to cause damage. The researchers identified the exact chemical modifications (S-palmitoylation and loss of S-sulfhydration) that control whether STING enters the mitochondria. They also confirmed that the glycolytic enzyme ENO1 was directly activated by STING, explaining how the energy system switched to the inefficient lactate-producing pathway. These details suggest multiple points where treatment could intervene.
Previous research recognized STING as an immune protein that fights infections, but this study reveals a completely new role in controlling how heart cells produce energy. Earlier work showed that diabetic hearts have mitochondrial problems and produce too much lactate, but the mechanism was unclear. This research connects those observations by identifying STING as the missing link. The finding that hydrogen sulfide protects against this damage builds on earlier studies showing that diabetes reduces hydrogen sulfide levels, but now explains the specific mechanism of protection.
This research was conducted entirely in mice and laboratory-grown cells, not in humans with diabetes. The findings may not directly apply to people because human physiology is more complex. The study used specific models of diabetes (genetic and diet-induced) that may not perfectly represent all types of human diabetes. The researchers did not test the proposed treatments (STING removal or hydrogen sulfide boosting) in living diabetic mice over long periods, so the long-term safety and effectiveness remain unknown. Additionally, the study focused on the heart and did not examine whether STING plays similar roles in other organs affected by diabetes.
The Bottom Line
Based on this research, potential future treatments might include drugs that block STING in the heart or therapies that boost hydrogen sulfide levels. However, these are still experimental approaches tested only in animals. Current diabetes management (controlling blood sugar, blood pressure, and cholesterol) remains the proven way to protect the heart. People with diabetes should continue following their doctor’s treatment plan while researchers work to develop new therapies based on these findings. Confidence level: This is early-stage research suggesting promising directions, not yet ready for clinical use.
People with diabetes who are concerned about heart complications should be aware of this research, as it may lead to better treatments in the future. Cardiologists treating diabetic patients should follow developments in STING-targeted therapies. Researchers studying diabetes and heart disease should consider STING’s metabolic role in their work. People without diabetes do not need to change their behavior based on this study.
If this research leads to human trials, it would typically take 5-10 years before new treatments become available to patients. The immediate impact will be on research directions and drug development efforts. People with diabetes should not expect changes to their treatment options in the near term based on this single study.
Frequently Asked Questions
What is STING and why does it matter for diabetic heart disease?
STING is a protein that controls immune responses, but research shows it also moves into heart cell power plants in diabetes and breaks their normal energy system. A 2026 study found that blocking STING improved heart function in diabetic mice, suggesting it’s a new treatment target.
How does diabetes damage the heart at the cellular level?
According to 2026 research, high blood sugar causes STING to enter mitochondria (cell power plants), disrupting their ability to produce energy efficiently. Heart cells then switch to an emergency system that produces harmful lactate buildup, damaging the heart over time.
Can hydrogen sulfide help protect diabetic hearts?
A 2026 Circulation Research study showed that boosting hydrogen sulfide levels with a drug called GYY4137 prevented STING from entering mitochondria and preserved heart function in diabetic mice, though human testing is still needed.
When will treatments based on this STING research be available?
This is early-stage research conducted in mice and cells. If development proceeds, human trials would typically take 5-10 years. Current diabetes management remains the proven way to protect the heart while researchers develop new therapies.
Should people with diabetes change their treatment based on this study?
No. This animal research suggests promising future directions but isn’t ready for human use yet. People with diabetes should continue following their doctor’s treatment plan for blood sugar, blood pressure, and cholesterol control, which are proven to protect the heart.
Want to Apply This Research?
- Users with diabetes could track their heart health markers: resting heart rate (measure daily), exercise capacity (note how far they can walk before fatigue), and blood sugar control (log readings). These are practical measures that reflect the heart function improvements shown in the research.
- Implement or maintain consistent aerobic exercise (30 minutes most days), as exercise improves mitochondrial function and may help prevent the STING-related damage described in this research. Users could set weekly exercise goals and log completion in the app.
- Create a long-term tracking dashboard showing trends in resting heart rate, exercise tolerance, and blood sugar control over months. This allows users to see whether their heart health is improving with current diabetes management, which is the proven way to prevent the type of damage this research describes.
This research was conducted in diabetic mice and laboratory-grown cells, not in humans. The findings suggest potential future treatment directions but are not yet ready for clinical use. People with diabetes should not change their current treatment based on this study. Consult with your healthcare provider about managing your diabetes and protecting your heart health. This article is for informational purposes only and should not be considered medical advice. Always discuss new research findings with your doctor before making any changes to your diabetes management plan.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.